1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Mutation: new trials by email Literature Review of Mutation trials Research Report on Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma mutation and signal pathway activation status analysis Drug: FORFIRINOX - Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer | Phase 2 | Unknown | Shanghai Jiao Tong University School of Medicine | 100 | 2016-07-01 | 2018-12-11 |
Shanghai Jiao Tong University School of Medicine (1)
China (1)